9.660USD-1.88%Mkt Cap: 81.91M USDP/E: —Last update: 2026-06-01
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap81.91M USD
Enterprise Value83.20M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-9.16M USD
Revenue/Share—
Last Price9.660 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees32
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-8.44
EV/Revenue—
P/S—
P/B54.69
EPS (TTM)-1.15
EPS (Forward)—
52W Range
7.08023% of range18.40
52W High18.40 USD
52W Low7.080 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-269.59%
ROA-153.37%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.50M USD
CapEx (TTM)169.92K USD
FCF Margin—
FCF Yield-4.84%
Net Debt-279.68K USD
Net Debt/EBITDA0.03
Balance Sheet
Debt/Equity0.37
Current Ratio1.32
Quick Ratio1.10
Book Value/Sh0.1800 USD
Cash/Share0.1700 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.8.48M
Float6.32M
Insiders71.12%
Institutions0.74%
Short Interest
Short Ratio4.2d
Short % Float0.29%
Short % Out.0.14%
Shares Short11.98K
Short (prev mo.)11.61K
Technical
SMA 509.557 (+1.1%)
SMA 20011.28 (-14.4%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)3.10K
Avg Vol (10d)4.34K
Technical Indicators
RSI (14)50.0
MACD0.0057
MACD Signal0.0076
MACD Hist.-0.0019
BB Upper10.42 USD
BB Middle9.839 USD
BB Lower9.257 USD
BB Width11.83%
ATR (14)0.5290 USD
Vol Ratio (20d)1.03x